First Header Logo Second Header Logo

Connection

Roger Royster to Myocardial Infarction

This is a "connection" page, showing publications Roger Royster has written about Myocardial Infarction.
Connection Strength

0.110
  1. Zvara DA, Groban L, Rogers AT, Prielipp RC, Murphy B, Hines M, Hammon JW, Kon ND, Royster RL. Prophylactic nitroglycerin did not reduce myocardial ischemia during accelerated recovery management of coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth. 2000 Oct; 14(5):571-5.
    View in: PubMed
    Score: 0.036
  2. Zvara DA, Galaska HJ, Castellano VP, Vinten-Johansen J, Royster RL, Williams MW, Murphy BA, Kim EJ. Cloricromene reduces myocardial infarct size in rabbits when administered during the early reperfusion period. Anesth Analg. 1997 Feb; 84(2):266-70.
    View in: PubMed
    Score: 0.028
  3. Zaloga GP, Prielipp RC, Butterworth JF, Royster RL. Pharmacologic cardiovascular support. Crit Care Clin. 1993 Apr; 9(2):335-62.
    View in: PubMed
    Score: 0.021
  4. Butterworth JF, Bean VE, Royster RL. Sufentanil is preferable to etomidate during rapid-sequence anesthesia induction for aortocoronary bypass surgery. J Cardiothorac Anesth. 1989 Aug; 3(4):396-400.
    View in: PubMed
    Score: 0.017
  5. Butterworth J, Legault C, Stump DA, Coker L, Hammon JW, Troost BT, Royster RL, Prough DS. A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1999 Dec; 13(6):690-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.